This paper studies the impact of equity considerations on the stability of international agreements between heterogeneous countries. We show that allowing countries to finance abatement projects in developing…

As the innovation process of pharmaceuticals is a long, risky and very costly business, economists typically emphasise lack of profit incentives and small market size as the most important obstacles to…

We investigate the importance of “what”-flexibility on top of “where”- and “when”-flexibility for alternative emission control schemes that prescribe long-term temperature targets and eventually impose…